絞り込み

16645

広告

Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants-a Systematic Review and Meta-analysis.

著者 Gu ZC , Wei AH , Zhang C , Wang XH , Zhang L , Shen L , Li Z , Pan MM , Liu XY , Pu J , Lin HW
Clin Gastroenterol Hepatol.2019 Jun 10 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (13view , 0users)

Full Text Sources

There is controversy over whether use of non-vitamin K antagonist oral anticoagulants (NOACs) associates with increased risk of major gastrointestinal bleeding (GIB) compared with conventional therapies (such as vitamin K antagonists or anti-platelet agents). We performed a systematic review and meta-analysis of data from randomized controlled trials and high-quality real-world studies.
PMID: 31195162 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード